Freenome, Inc. (FRNM) stock
FRNMNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026
$9.82−0.27 (-2.68%)
Close on Nov 17, 2026Market cap $1.09BP/E –Yield –
Freenome cash
Cash and short-term investments held at the end of each period.
Freenome's cash was $180.38M at Sep 30, 2026. For fiscal 2025 it was $78.56M, up 3.1% from the year before.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $78.56M | +3.1% |
| FY2024 | Dec 31, 2024 | $76.17M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $180.38M | +143.8% |
| Q2 FY2026 | Jun 30, 2026 | $437.37K | -67.5% |
| Q1 FY2026 | Mar 31, 2026 | $567.18K | -52.4% |
| Q4 FY2025 | Dec 31, 2025 | $78.56M | +3.1% |
| Q3 FY2025 | Sep 30, 2025 | $73.98M | +6017.1% |
| Q2 FY2025 | Jun 30, 2025 | $1.34M | +4.5% |
| Q1 FY2025 | Mar 31, 2025 | $1.19M | – |
| Q4 FY2024 | Dec 31, 2024 | $76.17M | – |
| Q3 FY2024 | Sep 30, 2024 | $1.21M | – |
| Q2 FY2024 | Jun 30, 2024 | $1.29M | – |
| Q1 FY2024 | Mar 31, 2024 | $0 | – |
See a number that looks wrong?